NORVIR tablets are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.
From the U.S. FDA-approved label for Ritonavir. Full label: DailyMed.
NORVIR tablets are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.
From the U.S. FDA-approved label for Ritonavir. Full label: DailyMed.
Adult patients: 600 mg twice-day with meals Pediatrics patients: Do not exceed 600 mg twice daily dose with meals for children greater than one month of age. The dose is based on body surface area Use NORVIR oral powder only for dosing increments of 100 mg Follow the Instructions for Use for preparation and administration of NORVIR oral powder Dose modification for NORVIR is necessary when used with other protease inhibitors 2.1 General Administration Recommendations NORVIR must be used in combination with other antiretroviral agents. Administer NORVIR orally.
Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.
Consult the prescribing information of the co-administered protease inhibitor for contraindication information for that product., NORVIR is contraindicated in patients with known hypersensitivity (e.g., toxic epidermal necrolysis (TEN) or Stevens-Johnson syndrome) to ritonavir or any of its ingredients., NORVIR is contraindicated with drugs that are highly dependent on CYP3A for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening reactions.
Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.
The following have been observed in patients receiving NORVIR: The concomitant use of NORVIR and certain other drugs may result in known or potentially significant drug interactions. Consult the full prescribing information prior to and during treatment for potential drug interactions. Hepatotoxicity: Fatalities have occurred.
Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.
The following adverse reactions are discussed in greater detail in other sections of the labeling. Drug Interactions Hepatotoxicity Pancreatitis Allergic Reactions/Hypersensitivity When co-administering NORVIR with other protease inhibitors, see the full prescribing information for that protease inhibitor including adverse reactions.
Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.
6 products from 5 makers in the NepalDoc medicine catalog use this generic:
| Brand | Composition | Maker | Pack |
|---|---|---|---|
| Ritomune 100mg Tablet | Ritonavir (100mg) | Cipla Ltd. | |
| Empetus 100mg Tablet | Ritonavir (100mg) | Emcure Pharmaceuticals Ltd | strip of 30 tablets |
| Ritomax 100mg Capsule | Ritonavir (100mg) | Alkem Laboratories Ltd | box of 60 capsules |
| Ritomax 100mg Tablet | Ritonavir (100mg) | Alkem Laboratories Ltd | strip of 30 tablets |
| Ritomune 100mg Capsule | Ritonavir (100mg) | Cipla Ltd | strip of 30 capsules |
| Viriton 100mg Tablet | Ritonavir (100mg) | Sun Pharmaceutical Industries Ltd | bottle of 60 tablets |
Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.
Storage Store at or below 30°C (86°F). Store at or below 30°C (86°F).
Storage information from the U.S. FDA-approved label.
Ritonavir is recorded in the NepalDoc medicine catalog for: HIV infection, AIDS.
For HIV infection: Efavirenz (EFV or EFZ), Filgrastim, Lamivudine (3TC), Lamivudine + Nevirapine + Zidovudine, Lamivudine + Zidovudine, Nevirapine (NVP), Zidovudine (ZDV or AZT).
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. NLEM listing does not guarantee that a medicine is in stock at any pharmacy.
